World's Best Scientists 2026 revealed!
Atsushi Natsume

Atsushi Natsume

D-Index & Metrics

Biology and Biochemistry

D-Index
60
Citations
9807
World Ranking
12201
National Ranking
840

Atsushi Natsume publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Atsushi Natsume sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 240 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Atsushi Natsume D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Atsushi Natsume sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 60 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Atsushi Natsume is affiliated with Nagoya University in Japan and has contributed extensively to research in medicine, with a strong focus on genetics, molecular biology, and neurology. Their work spans diverse areas within cancer research and pulmonary and respiratory medicine.

The scientist's research topics cover multiple aspects of neuro-oncology and cancer diagnostics, including:

  • Glioma Diagnosis and Treatment
  • Meningioma and schwannoma management
  • Cancer Genomics and Diagnostics
  • Extracellular vesicles in disease
  • Brain Metastases and Treatment
  • MicroRNA in disease regulation
  • Neuroblastoma Research and Treatments

Among their frequent co-authors are:

  • Toshihiko Wakabayashi
  • Fumiharu Ohka
  • Kosuke Aoki
  • Kazuya Motomura
  • Junya Yamaguchi

Natsume has published predominantly in journals focused on neuro-oncology and brain tumor pathology. Frequent venues include:

  • Neuro-Oncology Advances
  • Neuro-Oncology
  • PubMed
  • World Neurosurgery
  • Brain Tumor Pathology

Key recent papers authored or co-authored by Natsume include:

  • "The first-in-human phase I study of a brain-penetrant mutant IDH1 inhibitor DS-1001 in patients with recurrent or progressive IDH1-mutant gliomas", 2022, Neuro-Oncology
  • "Effect of CRISPR/Cas9-Mediated PD-1-Disrupted Primary Human Third-Generation CAR-T Cells Targeting EGFRvIII on In Vitro Human Glioblastoma Cell Growth", 2020, Cells
  • "Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1)", 2020, International Journal of Clinical Oncology
  • "Efficacy of cancer-specific anti-podoplanin CAR-T cells and oncolytic herpes virus G47Δ combination therapy against glioblastoma", 2022, Molecular Therapy - Oncolytics
  • "Ependymoma-like tumor with mesenchymal differentiation harboring C11orf95-NCOA1/2 or -RELA fusion: A hitherto unclassified tumor related to ependymoma", 2021, Brain Pathology

Best Publications

  • Mutational landscape and clonal architecture in grade II and III gliomas

    Hiromichi Suzuki;Kosuke Aoki;Kenichi Chiba;Yusuke Sato

  • Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment

    Keisuke Katsushima;Atsushi Natsume;Fumiharu Ohka;Fumiharu Ohka;Keiko Shinjo

  • Prognostic relevance of genetic alterations in diffuse lower-grade gliomas.

    Kosuke Aoki;Kosuke Aoki;Hideo Nakamura;Hiromichi Suzuki;Hiromichi Suzuki;Keitaro Matsuo

  • Novel somatic and germline mutations in intracranial germ cell tumours

    Linghua Wang;Shigeru Yamaguchi;Matthew D. Burstein;Keita Terashima

  • IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide.

    Atsushi Natsume;Dai Ishii;Toshihiko Wakabayashi;Takaya Tsuno

  • Current Trends in Targeted Therapies for Glioblastoma Multiforme

    Fumiharu Ohka;Atsushi Natsume;Toshihiko Wakabayashi

  • Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas

    Wentao Gao;Yutaka Kondo;Lanlan Shen;Yasuhiro Shimizu

  • Podoplanin: An emerging cancer biomarker and therapeutic target.

    Harini Krishnan;Julie Rayes;Tomoyuki Miyashita;Genichiro Ishii

  • Intravenously transplanted human neural stem cells migrate to the injured spinal cord in adult mice in an SDF-1- and HGF-dependent manner

    Hiroki Takeuchi;Atsushi Natsume;Toshihiko Wakabayashi;Chihiro Aoshima

  • Efficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells

    T Kato;A Natsume;H Toda;H Iwamizu

  • The global DNA methylation surrogate LINE-1 methylation is correlated with MGMT promoter methylation and is a better prognostic factor for glioma.

    Fumiharu Ohka;Atsushi Natsume;Kazuya Motomura;Yugo Kishida

  • Quantitative metabolome analysis profiles activation of glutaminolysis in glioma with IDH1 mutation

    Fumiharu Ohka;Maki Ito;Melissa Ranjit;Takeshi Senga

  • Antitumor effect and cellular immunity activation by murine interferon-beta gene transfer against intracerebral glioma in mouse.

    A Natsume;M Mizuno;Y Ryuke;J Yoshida

  • The DNA demethylating agent 5‐aza‐2′‐deoxycytidine activates NY‐ESO‐1 antigenicity in orthotopic human glioma

    Atsushi Natsume;Toshihiko Wakabayashi;Kunio Tsujimura;Shinji Shimato

  • EGFR mutations in patients with brain metastases from lung cancer: association with the efficacy of gefitinib.

    Shinji Shimato;Tetsuya Mitsudomi;Takayuki Kosaka;Yasushi Yatabe

  • Benefits of interferon-β and temozolomide combination therapy for newly diagnosed primary glioblastoma with the unmethylated MGMT promoter: A multicenter study.

    Kazuya Motomura;Atsushi Natsume;Yugo Kishida;Hiroyuki Higashi

  • Expression of miR-17-92 enhances anti-tumor activity of T-cells transduced with the anti-EGFRvIII chimeric antigen receptor in mice bearing human GBM xenografts

    Masasuke Ohno;Takayuki Ohkuri;Akemi Kosaka;Kuniaki Tanahashi

  • CAR T cells targeting podoplanin reduce orthotopic glioblastomas in mouse brains

    Satoshi Shiina;Masasuke Ohno;Fumiharu Ohka;Shunichiro Kuramitsu

  • Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma

    Atsushi Natsume;Motokazu Ito;Keisuke Katsushima;Fumiharu Ohka

  • Effectiveness of plasma treatment on gastric cancer cells

    Koji Torii;Suguru Yamada;Kae Nakamura;Hiromasa Tanaka

Frequent Co-Authors

Yukinari Kato
Yukinari Kato Tohoku University
Seishi Ogawa
Seishi Ogawa Kyoto University
Atsushi Enomoto
Atsushi Enomoto Nagoya University
Satoru Miyano
Satoru Miyano Tokyo Medical and Dental University
Ho Keung Ng
Ho Keung Ng Chinese University of Hong Kong
Masahide Takahashi
Masahide Takahashi Nagoya University
Mika K. Kaneko
Mika K. Kaneko Tohoku University
Yoshitaka Sekido
Yoshitaka Sekido Nagoya University
Joseph C. Glorioso
Joseph C. Glorioso University of Pittsburgh
Richard A. Gibbs
Richard A. Gibbs Baylor College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry in the USA opens doors to a wide range of in-demand healthcare careers. Many students explore roles in health information management, medical billing, and nutrition fields that all benefit from strong scientific backgrounds.

One popular path is becoming a medical coder, a key role in organizing and managing patient healthcare data. Understanding the medical.coder salary can help you assess if this career fits your financial goals. It’s also important to weigh the benefits and challenges when deciding is medical billing and coding worth it for you.

For those looking to expand career options, pursuing an online him degree can provide advanced skills for managing health records and data systems. Nutrition is another growing area—if you’re considering advanced study, reviewing the cost of masters degree in nutrition can help with financial planning.

By combining your science education with online degrees or certifications, you can unlock diverse and rewarding career pathways in the healthcare sector.

Best Scientists Citing Atsushi Natsume

Trending Scientists

Recently Published Articles